Keywords: vaccines, boost, sanofi-aventis, 1st-half, french/german, reforms, hit
Vaccines boost Sanofi-Aventis 1st-half but French/German reforms hit drug sales
Article | 07 August 2006
French pharmaceutical major Sanofi-Aventis has raised its full-year 2006 guidance based on its first-half performance to earnings per share growth, barring ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
